We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications
Looking for a particular Gero employee's phone or email?
The Gero annual revenue was $5.9 million in 2026.
Peter Fedichev is the Co-founder and CEO of Gero.
62 people are employed at Gero.
Gero is based in Palo Alto, California.
The NAICS codes for Gero are [541711, 5417, 541, 54, 32, 325, 54171].
The SIC codes for Gero are [28, 283, 2834].